Company Profile

Advanced Reproductive Testing (ART) is developing technologies designed to advance the detection and treatment of pregnancy related disorders, providing clinicians and expecting parents the information needed to manage pregnancies at risk. The team is currently developing a new product line named papseek - safe and simple tests that will be able to educate families and clinicians about the status of pregnancy and the genetic health of the baby as early as five weeks of pregnancy. The effort is to make available a 'standard' sampling kit that can be used safely by a health professional to collect and ship a sample. Samples will be de-identified to protect customer privacy and made accessible according to federal laws and regulations. The first set of tests under development are focused on gender determination and on the genetic carrier status (Sickle cell) from DNA of the baby obtained by the pap smear.